PhotoCure ASA | Cash Flow

Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
67,154.00
6,653.00
28,070.00
12,779.00
41,580.00
36,714
Depreciation, Depletion & Amortization
1,460.00
1,469.00
3,899.00
7,853.00
12,108.00
13,211
Other Funds
-
-
-
1,270.00
-
2,227
Funds from Operations
68,959.00
5.00
17,801.00
30,374.00
27,679.00
25,730
Changes in Working Capital
25,233.00
1,955.00
2,245.00
8,787.00
6,396.00
2,731
Net Operating Cash Flow
94,192.00
1,950.00
20,046.00
21,587.00
21,283.00
22,999
Capital Expenditures
1,155.00
956.00
14,933.00
22,102.00
18,588.00
Sale of Fixed Assets & Businesses
143.00
208.00
3.00
387.00
-
Purchase/Sale of Investments
-
-
-
30,674.00
-
Net Investing Cash Flow
1,012.00
748.00
13,588.00
11,498.00
18,588.00
Net Financing Cash Flow
40,356.00
686.00
2,415.00
2,128.00
-
Net Change in Cash
135,560.00
2,012.00
31,219.00
35,213.00
39,871.00
Free Cash Flow
95,347.00
2,906.00
20,569.00
18,052.00
22,333.00
Other Sources
-
-
1,342.00
2,539.00
-
Change in Capital Stock
40,356.00
686.00
2,415.00
3,398.00
-

About PhotoCure ASA

View Profile
Address
Hoffsveien 4
Oslo PS 0275
Norway
Employees -
Website http://www.photocure.com
Updated 07/08/2019
Photocure ASA is a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment. It operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.